Testosterone evaluation
done properly.
Low testosterone is real, common, and frequently mismanaged. At Well Endocrinology, evaluation starts with identifying why levels are low — not with a prescription.
Endocrinology, Obesity Medicine
Specialist access on your schedule.
Most testosterone prescribing skips the evaluation.
Fatigue, brain fog, and weight gain have multiple causes. Testosterone is one of them. Prescribing without ruling out the others is how patients end up on therapy they don't need.
At Well Endocrinology, the first step is determining whether testosterone therapy is medically indicated — not whether a patient is interested in it. That means evaluating the metabolic, hormonal, and systemic factors that commonly mimic or contribute to low testosterone before any treatment decisions are made.
Why testosterone levels decline
Aging accounts for a gradual physiologic decline. But symptomatic hypogonadism in middle-aged men is often driven by modifiable metabolic factors rather than aging alone. Identifying the underlying cause changes the treatment approach.
Aging
Obesity and visceral fat
Insulin resistance
Obstructive sleep apnea
Alcohol use
Chronic illness
Medication effects
Pituitary disorders
Treatment starts with the right diagnosis.
At Well Endocrinology, evaluation is not a checkbox before prescribing. It is the clinical work that determines whether testosterone therapy is appropriate — and whether treating the underlying cause is a better first step.
Laboratory evaluation
Morning fasting testosterone with repeat confirmation. LH and FSH to distinguish primary from secondary hypogonadism. Prolactin, thyroid function, CBC, and metabolic panel as clinically indicated.
Metabolic assessment
Obesity, insulin resistance, obstructive sleep apnea, chronic disease, and medication effects are systematically evaluated. InBody body composition analysis is included for all new patients.
Individualized planning
Fertility goals, symptom severity, cardiovascular risk, and long-term safety are reviewed before any treatment decision. Testosterone therapy is one option — not the automatic answer.
For patients where therapy is appropriate: safety, monitoring, and metabolic context.
Individualized treatment
Formulation, route, and dosing are matched to symptoms, laboratory findings, fertility goals, and metabolic status. Injection, gel, and pellet options are reviewed with their respective tradeoffs.
Ongoing monitoring
Follow-up includes testosterone levels, hematocrit, PSA where indicated, lipid panel, and symptom reassessment. Dose adjustments are based on clinical response.
Metabolic context
The goal is symptom improvement and long-term safety. Supraphysiologic testosterone levels are not the target. If underlying metabolic drivers can be addressed, that is addressed first.
On hematocrit monitoring: Testosterone therapy raises red blood cell production. Elevated hematocrit increases blood viscosity and thrombotic risk. Monitoring is a standard safety requirement — not optional. Dose reduction or temporary discontinuation may be necessary if hematocrit rises above threshold.
Yes, and this is one of the most clinically important things to understand. Visceral adipose tissue converts testosterone to estrogen via aromatase, and chronically elevated insulin suppresses hypothalamic GnRH signaling. The result is secondary hypogonadism that is, in part, metabolically driven. Weight loss in obese men is associated with meaningful increases in testosterone — which is why metabolic treatment is evaluated before or alongside testosterone therapy in this context.
Yes. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing LH and FSH and decreasing sperm production. This effect is generally reversible, but recovery can take months. Fertility goals must be discussed before starting therapy. Men who want to preserve fertility may be candidates for alternative approaches such as clomiphene citrate or HCG.
No. Fatigue is one of the least specific symptoms in clinical medicine. Sleep apnea, iron deficiency, hypothyroidism, depression, uncontrolled diabetes, and medication effects all cause fatigue. If testosterone levels are confirmed low on repeat morning testing and contributing causes have been evaluated, fatigue may be one component of a broader clinical picture that supports therapy. It is not sufficient on its own.
Testosterone stimulates erythropoiesis, which can cause polycythemia — an abnormal rise in red blood cell mass. Elevated hematocrit increases blood viscosity and raises the risk of thrombotic events including stroke and pulmonary embolism. Monitoring hematocrit at baseline and regularly during treatment is a standard safety requirement. If hematocrit rises significantly, dose reduction, a treatment hold, or therapeutic phlebotomy may be required.
There is no single threshold. Endocrine Society guidelines recommend confirming two low morning testosterone levels in the setting of consistent symptoms before considering therapy. A testosterone level in the low-normal range without symptoms is not an indication for treatment. The clinical picture — symptoms, laboratory findings, underlying causes, and patient goals — determines the decision, not a single number.
No. Well Endocrinology is a direct-care practice. Visit fees are paid directly — no insurance required for consultations. Lab work and imaging run through your insurance. Medications are prescribed through your pharmacy and covered per your plan. No prior authorization delays, no surprise bills.
From the Well Endocrinology blog
Is Testosterone Replacement Right for You? Key Considerations
The Direct-Care Approach to Obesity: Personalized Treatment for Lasting Metabolic Health
2026 Cholesterol Guidelines: What Changed and What It Means for Your Heart Risk
Rewrite Your Health Story: Precision Approach to Longevity, Metabolic Health & Heart Disease
Concerned about low testosterone?
Work directly with a board-certified endocrinologist for a comprehensive hormonal and metabolic evaluation. No referral required. No insurance needed for visits.
Schedule consultationInitial consultation $600 · Membership $300/month · Direct-care model
